延长胸主动脉腔内修复术是急性复杂型B型夹层的最佳治疗
回顾性分析2012至2018年92例因复杂急性B型主动脉夹层行胸主动脉腔内修复术的患者,比较标准覆盖(3、4区,n=40)与延长覆盖(3至5区,n=52)。延长组覆盖长度更长,胸段假腔完全血栓形成/闭塞率更高(82.2% vs 51.5%,P=0.04),远端主动脉再干预更少(5.8% vs 20%,P=0.04),晚期主动脉特异性生存率两组无显著差异。
要点
- 延长胸主动脉腔内修复术覆盖3至5区,覆盖长度240±32 mm vs 标准组183±23 mm(P<0.01)。
- 延长组胸段假腔完全血栓形成/闭塞率82.2% vs 标准组51.5%(P=0.04)。
- 延长组远端主动脉再干预率5.8% vs 标准组20%(P=0.04)。
核心结论
- 延长胸主动脉腔内修复术治疗复杂急性B型主动脉夹层安全,胸段假腔完全血栓形成/闭塞率高,并减少远端再干预。
- 需要更长期随访以证明与限制性主动脉覆盖相比的生存获益。
研究设计与样本
- 回顾性分析Emory主动脉数据库2012至2018年92例因复杂急性B型主动脉夹层行胸主动脉腔内修复术的患者。
- 标准胸主动脉腔内修复术覆盖主动脉3区和4区(从左锁骨下动脉至胸降主动脉中段),延长组覆盖3至5区(从左锁骨下动脉至腹腔干),标准组n=40,延长组n=52。
主要发现
- 延长组覆盖长度240±32 mm vs 标准组183±23 mm(P<0.01)。
- 院内死亡率5.4%(延长组7.7% vs 标准组2.5%;P=0.27),死因为肠系膜灌注不良(n=3)或破裂(n=2)。
- 术后卒中总体发生率5.4%(延长组3.9% vs 标准组7.5%;P=0.38),一过性轻瘫3.2%(延长组5.8% vs 标准组0%;P=0.18),截瘫0%,透析0%,两组相当。
- 随访至平均6.1年(四分位距3.5-8.6年)完整率96.6%,延长组胸段假腔完全血栓形成/闭塞率82.2% vs 标准组51.5%(P=0.04)。
- 延长组远端主动脉再干预率5.8% vs 标准组20%(P=0.04),晚期主动脉特异性生存率延长组98.1% vs 标准组92.3%(P=0.32)。
临床怎么用
- 作者认为延长胸主动脉腔内修复术治疗复杂急性B型主动脉夹层安全,胸段假腔完全血栓形成/闭塞率高,并减少远端再干预。
- 作者指出需要更长期随访以证明与限制性主动脉覆盖相比的生存获益。
局限性
- 需要更长期随访以证明与限制性主动脉覆盖相比的生存获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thoracic endovascular aortic repair (TEVAR) represents optimal therapy for complicated acute type B aortic dissection (aTBAD). Persistent knowledge gaps remain, including the optimal length of aortic coverage, impact on distal aortic remodeling, and fate of the dissected abdominal aorta. METHODS: Review of the Emory Aortic Database identified 92 patients who underwent TEVAR for complicated aTBAD from 2012 to 2018. Standard TEVAR covered aortic zones 3 and 4 (from the left subclavian to the mid-descending thoracic aorta). Extended TEVAR fully covered aortic zones 3 though 5 (from the left subclavian to the celiac artery). Long-term imaging, clinical follow-up, and overall and aortic-specific mortality were reviewed. RESULTS: Extended TEVAR (n = 52) required a greater length of coverage vs standard TEVAR (n = 40) (240 ± 32 mm vs 183 ± 23 mm; P < .01). In-hospital mortality occurred in 5.4% of patients (7.7% vs 2.5%; P = .27) owing to mesenteric malperfusion (n = 3) or rupture (n = 2). The overall incidences of postoperative stroke, transient paraparesis, paraplegia, and dialysis were 5.4% (3.9% vs 7.5%; P = .38), 3.2% (5.8% vs 0%; P = .18), 0%, and 0% respectively, equivalent between groups. Follow-up was 96.6% complete to a mean of 6.1 years (interquartile range, 3.5-8.6 years). There were significantly higher rates of complete thrombosis or obliteration of the entire thoracic false lumen after Extended TEVAR (82.2% vs 51.5%; P = .04). Distal aortic reinterventions were less frequent after extended TEVAR (5.8% vs 20%; P = .04). Late aorta-specific survival was 98.1% after extended TEVAR vs 92.3% for standard TEVAR (P = .32). CONCLUSIONS: Extended TEVAR for complicated aTBAD is safe, results in a high rate of total thoracic false lumen thrombosis/obliteration, and reduces distal reinterventions. Longer-term follow-up will be needed to demonstrate a survival benefit compared to limited aortic coverage.
引用
- Nissen AP, Huckaby LV, Duwayri YM, et al. Extended thoracic endovascular aortic repair is optimal therapy in acute complicated type B dissection. J Vasc Surg. 2024. PMID: 38750944. doi:10.1016/j.jvs.2024.05.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。